Drug Profile
Menabitan
Alternative Names: HGP 3; SP 204Latest Information Update: 08 Feb 2008
Price :
$50
*
At a glance
- Originator HG Pars
- Class Analgesics; Anti-inflammatories; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation; Pain
Most Recent Events
- 22 Apr 1997 No-Development-Reported for Inflammation in USA (Unknown route)
- 22 Apr 1997 No-Development-Reported for Pain in USA (Unknown route)